Gilead Sciences
Developing innovative healthcare solutions
- B2B
- Has physical offices
- Publicly traded
- Manufacturing
- Multi-product
- Sales-led purchase
About Gilead Sciences
A company focused on delivering innovative medicines in virology and oncology, addressing health inequities, and empowering people to live healthier lives
Key facts
- Industry
- Biotechnology Research
- Company size
- 10,000+ employees
- Headquarters
- Foster City, California, United States
- Founded
- 1987
- Revenue
- $29.4BFY2025, publicly reported
- Website
- gilead.com
Jobs at Gilead Sciences
- Associate Director, Operations Oversight Lead Medical Affairs Research Global Operations (MARGO)
- Assoc Director, Operations Oversight Lead Medical Affairs Research Global Operations (MARGO)
- Intern - Kite Development - Global Patient Safety
- Senior Manager, Global HIV Prevention Medical Affairs
- Assoc Director, Global Insights & Analytics
- Intern - Kite - Corporate Operational Excellence
- Director, Global Process Owner (GPO) of Event Management & CAPA
- Sr Director, IT Head of Security Operations
Gilead Sciences in the news
- Gilead Accelerates Global Access Planning for Investigational Once-Yearly Lenacapavir for HIV Prevention
Gilead Sciences expanded licensing agreements for investigational once-yearly lenacapavir to support global manufacturing and supply for HIV prevention in 120 high-incidence countries.
- Gilead, PAHO agree on HIV prevention drug access in Latin America, Caribbean
Gilead Sciences partnered with the Pan American Health Organization to expand access to its HIV prevention drug, lenacapavir, in Latin America and the Caribbean, addressing a rise in new infections.
- Gilead Partners With Pan American Health Organization on Lenacapavir Access for Latin America, Caribbean
Gilead Sciences and the Pan American Health Organization are collaborating to improve access to lenacapavir for HIV prevention in Latin America and the Caribbean.
- PAHO opens a new pathway to access lenacapavir for HIV prevention in Latin America and the Caribbean
PAHO partnered with Gilead Sciences to expand access to the long-acting HIV prevention medicine lenacapavir in 14 Latin American and Caribbean countries.
- Should Gilead Sciences (GILD) Reconsider Its Global HIV Case After This PAHO Deal?
Gilead Sciences partnered with the Pan American Health Organization to expand access to its HIV prevention drug, lenacapavir, across 14 Latin American and Caribbean countries.
Gilead Sciences at a glance
Gilead Sciences is a B2B company in the Biotechnology Research industry, headquartered in Foster City, California, United States.
Gilead Sciences was founded in 1987.
Gilead Sciences has 10,000+ employees.
Gilead Sciences's revenue is $29.4B (FY2025, publicly reported).
Gilead Sciences is hiring: 8 recent open roles, including Associate Director, Operations Oversight Lead Medical Affairs Research Global Operations (MARGO), Assoc Director, Operations Oversight Lead Medical Affairs Research Global Operations (MARGO), Intern - Kite Development - Global Patient Safety.
Selling to companies like Gilead Sciences?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies